Rubicon Research announced the acquisition of MeditabSpecialities’ oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. MeditabSpecialities is a wholly-owned subsidiary of Cipla.
Everstone’s Singapore fund had acquired a controlling stake in Rubicon and along with co-investor Mankekars, bought out Kotak Private Equity and other shareholders and also invested primary capital in the company